✦ LIBER ✦

Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population

✍ Scribed by Pantep Angchaisuksiri; Sarinee Pingsuthiwong; Katcharin Aryuchai; Manisa Busabaratana; Thanyachai Sura; Vichai Atichartakarn; Piyamitr Sritara

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 28 KB
Volume: 65
Category: Article
ISSN: 0361-8609
DOI: 10.1002/1096-8652(200010)65:2<119::aid-ajh5>3.0.co;2-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence of factor V G1691A (factor V-

Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population

✍ Ramzi R. Finan; Hala Tamim; Ghada Ameen; Huda E. Sharida; Mooza Rashid; Wassim Y 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Factor V leiden and prothrombin gene G20

Factor V leiden and prothrombin gene G20210A mutation in children with cerebral thromboembolism

✍ Mariana Bonduel; Gabriela Sciuccati; Mirta Hepner; Graciela Pieroni; Aurora Feli 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

Prothrombin gene 20210 G-A mutation in t

Prothrombin gene 20210 G-A mutation in the Turkish population

✍ Akar, Nejat; Misirlioglu, Müge; Akar, Ece; Avcu, Ferit; Yalçin, Atilla; Sözüöz, 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

to permit rapid consideration for publication. ## Simultaneous Occurrence of Lupus Anticoagulant and Factor VIII Inhibitors in Hemophilia To the Editor: The letter published in the November 1997 issue, regarding simultaneous occurrence of lupus anticoagulant (LA) and factor VIII inhibitors [1,2],

Combined heterozygosity of factor V Leid

Combined heterozygosity of factor V Leiden and the G20210A prothrombin gene mutation in a patient with cerebral cortical vein thrombosis

✍ Xiao-Yuan Liu; Theodore G. Gabig; Nils U. Bang 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 18 KB

Prevalence of factor V Leiden, prothromb

Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in a Greek population of blood donors

✍ Antoniadi, T.; Hatzis, T.; Kroupis, C.; Economou-Petersen, E.; Petersen, M.B. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 19 KB

The pathogenesis of venous thrombosis involves the interaction of genetic and environmental factors. In order to estimate the frequency of the factor V Leiden, the prothrombin G20210A, and the MTHFR C677T mutations in the Greek population, we analyzed 160 healthy Greek blood donors by PCR amplificat

Prevalence of the factor V-Leiden mutati

Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations

✍ Gregg, Jeff P.; Yamane, Akemi J.; Grody, Wayne W. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 8 KB 👁 2 views

Resistance to activated protein C (APC) is the most common risk factor for venous thromboembolism, a major cause of morbidity and mortality with an incidence of about 1/1,000 per year. The Arg 506 to Gln mutation in exon 10 of the coagulation factor V gene (factor V-Leiden) has been found to be resp